Steph & Co’s Sanofi SNY Stock Holding History

Steph & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-86	Closed	-$4.17K	–	320
2025 Q4	$4.17K	Buy	+86	New	+$4.26K	﹤0.01%	299

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Steph & Co's SNY Position: Q1 2026 in Review

Steph & Co sold out of Sanofi (SNY) in Q1 2026, closing a stake of 86 shares — an estimated $4.17K sold.

Steph & Co first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $4.17K in Q4 2025. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Steph & Co reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Steph & Co sold 86 Sanofi shares in Q1 2026, an estimated $4.17K.
Steph & Co first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
Steph & Co's Sanofi position peaked at $4.17K in Q4 2025.
745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Steph & Co's 13F filing for Q1 2026, filed 17 Apr 2026.